Experienced in Peripheral T-Cell Lymphoma

Dr. Leona A. Holmberg

Hematology Oncology | Oncology
The Association Of University Physicians
1701 Columbia Rd, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Peripheral T-Cell Lymphoma
The Association Of University Physicians
1701 Columbia Rd, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Leona Holmberg is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Holmberg is rated as an Experienced provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Multiple Myeloma, Mantle Cell Lymphoma (MCL), Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Holmberg is currently accepting new patients.

Her clinical research consists of co-authoring 105 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Peripheral T-Cell Lymphoma.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in WA
Languages Spoken
English
Korean
Mandarin
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

THE ASSOCIATION OF UNIVERSITY PHYSICIANS
1701 Columbia Rd, Seattle, WA 98195
Other Locations
THE ASSOCIATION OF UNIVERSITY PHYSICIANS
825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
Alternating the Administration of Ixazomib and Lenalidomide as Maintenance Therapy After Autologous Transplant for Treating Multiple Myeloma
Alternating the Administration of Ixazomib and Lenalidomide as Maintenance Therapy After Autologous Transplant for Treating Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2025
Intervention Type: Drug, Other
Study Drugs: Ixazomib Citrate, Lenalidomide
Study Phase: Phase 2
A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients With High-Risk Classical Hodgkin Lymphoma
A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients With High-Risk Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Brentuximab, Nivolumab
Study Phase: Phase 2
Autologous Transplant as Treatment for Favorable or Intermediate Risk MRD-Negative AML Patients After Initial Induction Therapy
Autologous Transplant as Treatment for Favorable or Intermediate Risk MRD-Negative AML Patients After Initial Induction Therapy
Enrollment Status: Withdrawn
Publish Date: February 01, 2021
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2
A Phase II Trial for Patients With Inflammatory (Stage IIIB) and Responsive Metastatic Stage IV Breast Cancer Using Busulfan, Melphalan and Thiotepa Followed by Autologous or Syngeneic PBSC Rescue and 12 Weeks of Post-Engraftment Immunotherapy With Low-Dose IL-2 and GM-CSF
A Phase II Trial for Patients With Inflammatory (Stage IIIB) and Responsive Metastatic Stage IV Breast Cancer Using Busulfan, Melphalan and Thiotepa Followed by Autologous or Syngeneic PBSC Rescue and 12 Weeks of Post-Engraftment Immunotherapy With Low-Dose IL-2 and GM-CSF
Enrollment Status: Completed
Publish Date: July 12, 2017
Intervention Type: Radiation, Procedure, Drug, Biological
Study Phase: Phase 2
View 4 Less Clinical Trials

105 Total Publications

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 09, 2025
Similar Doctors
Elite in Peripheral T-Cell Lymphoma
Dr. Andrei R. Shustov
Hematology Oncology
Elite in Peripheral T-Cell Lymphoma
Dr. Andrei R. Shustov
Hematology Oncology
825 Eastlake Avenue E, G3-200, 
Seattle, WA 
 (1.8 miles away)
206-288-6739
Languages Spoken:
English, German, Portuguese, Russian, Ukrainian
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrei Shustov is a Hematologist Oncology provider in Seattle, Washington. Dr. Shustov is rated as an Elite provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shustov is currently accepting new patients.

Advanced in Peripheral T-Cell Lymphoma
Dr. Sirisha M. Jain
Hematology Oncology | Hematology | Oncology
Advanced in Peripheral T-Cell Lymphoma
Dr. Sirisha M. Jain
Hematology Oncology | Hematology | Oncology

Franciscan Medical Group

19500 10th Ave Ne, Suite 100, 
Poulsbo, WA 
 (16.5 miles away)
360-598-7500
Languages Spoken:
English, Amharic, Portuguese, Russian, Spanish, Ukrainian, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Sirisha Jain is a Hematologist Oncology specialist and a Hematologist in Poulsbo, Washington. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jain is currently accepting new patients.

Advanced in Peripheral T-Cell Lymphoma
Dr. Mazyar S. Shadman
Hematology Oncology | Oncology | Hematology
Advanced in Peripheral T-Cell Lymphoma
Dr. Mazyar S. Shadman
Hematology Oncology | Oncology | Hematology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.8 miles away)
206-288-1000
Languages Spoken:
English, Farsi, Hebrew, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mazyar Shadman is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Shadman is rated as an Elite provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Shadman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Holmberg's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile